HBI-3000 Prevents Secondary Sudden Cardiac Death

Conclusions:
The data indicate that HBI is an effective antiarrhythmic and antifibrillatory agent for the prevention of VF or sudden cardiac death.

Source: Journal of Cardiovascular Pharmacology and Therapeutics - August 12, 2013 Category: Cardiology Authors: Lee, J. Y., Lucchesi, B. R. Tags: Experimental Studies Source Type: research